111 related articles for article (PubMed ID: 24909811)
1. Glucagon-like peptide-1 analog-mediated protection against cholesterol-induced apoptosis via mammalian target of rapamycin activation in pancreatic βTC-6 cells -1mTORβTC-6.
Zhou J; Wu J; Zheng F; Jin M; Li H
J Diabetes; 2015 Mar; 7(2):231-9. PubMed ID: 24909811
[TBL] [Abstract][Full Text] [Related]
2. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
3. Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner.
Zhao H; Wei R; Wang L; Tian Q; Tao M; Ke J; Liu Y; Hou W; Zhang L; Yang J; Hong T
Am J Physiol Endocrinol Metab; 2014 Jun; 306(12):E1431-41. PubMed ID: 24801389
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo.
Yang P; Zhao Y; Zhao L; Yuan J; Chen Y; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
Sci Rep; 2015 Oct; 5():14959. PubMed ID: 26449763
[TBL] [Abstract][Full Text] [Related]
6. [Protective effect of glucagon-like peptide-1 analogue on cardiomyocytes injury induced by hypoxia/reoxygenation].
Liu MM; Shen YF; Chen C; Lai XY; Zhang MY; Yu R
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):311-6. PubMed ID: 27030622
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.
Farrelly AM; Kilbride SM; Bonner C; Prehn JH; Byrne MM
Apoptosis; 2011 Nov; 16(11):1128-37. PubMed ID: 21874357
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway.
Kimura R; Okouchi M; Fujioka H; Ichiyanagi A; Ryuge F; Mizuno T; Imaeda K; Okayama N; Kamiya Y; Asai K; Joh T
Neuroscience; 2009 Sep; 162(4):1212-9. PubMed ID: 19463904
[TBL] [Abstract][Full Text] [Related]
9. Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway.
Shao S; Nie M; Chen C; Chen X; Zhang M; Yuan G; Yu X; Yang Y
J Cell Biochem; 2014 Jun; 115(6):1166-75. PubMed ID: 24415347
[TBL] [Abstract][Full Text] [Related]
10. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway.
Li B; Yang J; Lu Z; Liu B; Liu F
J BUON; 2019; 24(2):739-745. PubMed ID: 31128031
[TBL] [Abstract][Full Text] [Related]
11. Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells.
Le Gendre O; Sookdeo A; Duliepre SA; Utter M; Frias M; Foster DA
Mol Cancer Res; 2013 May; 11(5):474-81. PubMed ID: 23443316
[TBL] [Abstract][Full Text] [Related]
12. Protection of pancreatic β-cells against glucotoxicity by short-term treatment with GLP-1.
Park SH; Park JH; Shim HM; Na AY; Bae KC; Lim JG; Song DK
Biochem Biophys Res Commun; 2015 Apr; 459(4):561-7. PubMed ID: 25757909
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
14. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
[TBL] [Abstract][Full Text] [Related]
15. Liraglutide Improves Endothelial Function via the mTOR Signaling Pathway.
Wu H; Xiao C; Zhao Y; Yin H; Yu M
J Diabetes Res; 2021; 2021():2936667. PubMed ID: 34447854
[TBL] [Abstract][Full Text] [Related]
16. [Effects of glucagon-like peptide-1 on the free fatty acid-induced expression of pancreatic derived factor in cultured β-TC3 cell line].
Chen S; Cao XP; Xiao HP; Li YB
Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1413-6. PubMed ID: 21756815
[TBL] [Abstract][Full Text] [Related]
17. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis.
Kimura R; Okouchi M; Kato T; Imaeda K; Okayama N; Asai K; Joh T
Neuroendocrinology; 2013; 97(4):300-8. PubMed ID: 23147408
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells.
Wang HW; Mizuta M; Saitoh Y; Noma K; Ueno H; Nakazato M
Metabolism; 2011 Aug; 60(8):1081-9. PubMed ID: 21255808
[TBL] [Abstract][Full Text] [Related]
20. DPP IV inhibitor suppresses STZ-induced islets injury dependent on activation of the IGFR/Akt/mTOR signaling pathways by GLP-1 in monkeys.
Zhang Y; Chen Y; Cheng J; Guo Z; Lu Y; Tian B
Biochem Biophys Res Commun; 2015 Jan; 456(1):139-44. PubMed ID: 25446112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
